New atypical epidemiological profile of parvovirus B19 revealed by molecular screening of blood donations, France, winter 2023/24.

Autor: Guillet M; Etablissement Français du Sang Centre Pays de Loire, Nantes, France., Bas A; Etablissement Français du Sang Auvergne Rhône Alpes, Lyon Décines, France., Lacoste M; Etablissement Français du Sang Occitanie, Toulouse, France., Ricard C; Etablissement Français du Sang Hauts de France-Normandie, Loos, France., Visse C; LFB - Biomédicaments, Control Laboratories, Courtaboeuf Cedex, France., Barlet V; Etablissement Français du Sang Auvergne Rhône Alpes, Lyon Décines, France., Malard L; Etablissement Français du Sang, La Plaine Saint-Denis, France., Le Cam S; Etablissement Français du Sang, La Plaine Saint-Denis, France., Morel P; Etablissement Français du Sang, La Plaine Saint-Denis, France., de Lamballerie X; Unité des Virus Émergents (UVE: Aix-Marseille Univ-Corsica Univ-IRD 190-Inserm 1207-IRBA), Marseille, France., Laperche S; Etablissement Français du Sang, La Plaine Saint-Denis, France., Gallian P; Unité des Virus Émergents (UVE: Aix-Marseille Univ-Corsica Univ-IRD 190-Inserm 1207-IRBA), Marseille, France.; Etablissement Français du Sang, La Plaine Saint-Denis, France.
Jazyk: angličtina
Zdroj: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2024 May; Vol. 29 (21).
DOI: 1560-7917.ES.2024.29.21.2400253
Abstrakt: In France, blood donations are tested in pools of 96 samples for parvovirus B19 (B19V) DNA to discard plasma for fractionation when it contains high viral loads. Between January 2015 and March 2024, B19V-positive donations decreased during the COVID-19 pandemic, followed by a strong rebound in 2023 and unusually high circulation during winter 2023/24 (ca 10 times higher December 2023-March 2024 vs the pre-pandemic period). Variations over time are probably related to measures implemented to limit SARS-CoV-2 spread.
Databáze: MEDLINE